Analystreport

Calithera Biosciences, Inc. (NASDAQ: CALA) is now covered by analysts at LADENBURG THALM/SH SH. They set a "buy" rating and a $4.00 price target on the stock.

Calithera Biosciences, Inc.  (CALA) 
Last calithera biosciences, inc. earnings: 3/11 04:10 pm Check Earnings Report
US:NASDAQ Investor Relations: calithera.com